UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 26 filers reported holding UROVANT SCIENCES LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 591,454 | $7,097,000 | 2.44% |
| Asymmetry Capital Management, L.P. | 158,463 | $1,902,000 | 1.76% |
| Ghost Tree Capital, LLC | 300,000 | $3,600,000 | 0.76% |
| DC Investments Management, LLC | 51,502 | $618,000 | 0.42% |
| Eventide Asset Management | 594,816 | $7,138,000 | 0.26% |
| Park West Asset Management LLC | 525,000 | $6,300,000 | 0.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 164,030 | $1,968,000 | 0.23% |
| Perceptive Advisors | 462,659 | $5,552,000 | 0.15% |
| Monashee Investment Management LLC | 52,500 | $630,000 | 0.13% |
| Point72 Hong Kong Ltd | 12,262 | $147,000 | 0.05% |